ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $322,185 | -13.1% | 7,967 | 0.0% | 0.01% | -36.4% |
| Q4 2022 | $370,625 | -10.3% | 7,967 | 0.0% | 0.01% | -67.6% |
| Q3 2022 | $413,000 | +18.0% | 7,967 | +7.6% | 0.03% | +209.1% |
| Q2 2022 | $350,000 | -32.4% | 7,403 | +1.7% | 0.01% | -21.4% |
| Q1 2022 | $518,000 | -2.8% | 7,277 | +2.0% | 0.01% | 0.0% |
| Q4 2021 | $533,000 | +33.6% | 7,134 | +0.8% | 0.01% | +27.3% |
| Q3 2021 | $399,000 | – | 7,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |